Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Bronchopulmonary dysplasia (BPD) is a serious lung condition that affects premature newborns.
The condition involves abnormal development of lung tissue and is characterized by
inflammation and scarring in the lungs. Treatment with inhaled nitric oxide (iNO) may reduce
the incidence of BPD and another commonly associated condition called pulmonary hypertension,
which is high blood pressure in the vessels carrying blood to the lungs.. This study will
determine if early treatment with low-dose iNO reduces the incidence of BPD, pulmonary
hypertension, and death in premature newborns.